Cygenex Debuts CyPHR AI Engine, Bridging Genetic Intelligence and Real-Time Education
United States, 30th Mar 2026 – Cygenex, a leader in precision medicine and pharmacogenomic risk optimization, today announced the launch of CyPHR™ (Cygenex Precision Health Response) an AI-powered health assistant designed to translate an individual’s genetic blueprint into actionable, real-time clinical guidance.
CyPHR represents a major advancement in the application of pharmacogenomics, bridging the gap between genetic insight and everyday healthcare decisions. By integrating DNA data, CyPHR, empowering both patients and providers to move from reactive care to proactive, precision-driven intervention.
Eliminating Trial-and-Error Medicine
Traditional prescribing models rely heavily on trial and error often resulting in ineffective therapies, adverse drug reactions, and avoidable healthcare costs. Cypher is an AI tool for educational purposes and is designed to help people better understand the science behind their pharmacogenomic results.
CyPHR replaces this outdated approach with DNA-driven precision, by educating individuals on their genetic profile. By cross-referencing genetic data with current medications, CyPHR educates the individual on potential risks and adverse interactions.
“For decades, healthcare has operated without visibility into one of the most critical variables individual biology,” said Charles Clark, CEO. “CyPHR changes that. It transforms static genetic data into a dynamic, real-time education tool that provides individuals insights into their path to better health.”
A 24/7 Digital Health Co-Pilot
CyPHR functions as a continuous, AI-powered health companion providing users with ongoing guidance. According to the product overview CyPHR’s Precision Health Assistant performs the following:
- Synthesize genetic, lifestyle, and health data into clear, actionable insights
- Provides 24/7 personalized guidance between clinical visits
- Identifies potential risks early and supports preventive interventions
- Translates complex health information into simple to understandable language.
This empowers individuals to take a more active role in their health.
From Data to Daily Life
Unlike traditional genetic reports that remain static and underutilized, CyPHR converts DNA insights into a living, evolving health roadmap.
“CyPHR is not just about testing. It’s about educating individuals on their genetic profile” said Sharyl Loggins, VP of Technology. “We are putting precision medicine directly into the hands of the individual.
Driving Measurable Health Impact
Early data highlights the potential of AI-driven, precision-guided care:
- Up to 95% reduction in error compared to manual health tracking
- Approximately 30% increase in adherence to healthier behaviors
By educating individuals on medication alignment, lifestyle choices, and enabling earlier intervention, CyPHR addresses one of healthcare’s most significant challenges, inefficiency driven by lack of personalization.
Enterprise-Grade Security
CyPHR is built on a secure, enterprise-grade infrastructure, ensuring that sensitive health and genetic data remain protected at all times and user data is:
- Stored within Microsoft’s secure cloud environment
- HIPAA and GINA compliant
- Never exposed to the public internet
- Governed by strict enterprise-level security and privacy protocols
A New Standard for Precision Medicine
CyPHR represents a foundational step toward a future where healthcare is no longer reactive, but predictive where treatment decisions are informed by biology, not guesswork.
With CyPHR, Cygenex is redefining how genetic data is used by transforming it from a static report into a continuous, intelligent system that guides educates individuals on better health outcomes.
About Cygenex
Cygenex is a precision medicine company focused on identifying and mitigating medication-driven risk through advanced pharmacogenomics, AI-driven analytics, and population health optimization. By aligning medications to individual biology, Cygenex helps employers, TPAs, and stop-loss carriers reduce healthcare costs while improving clinical outcomes.
For More Product Information Contact:
Cygenex
Email: info@cygenex.com
Company Details
Organization: Cygenex
Contact Person: Media Relations
Website: https://cygenex.com
Email: Send Email
Country: United States
Release Id: 30032643204